Neural effects of green tea extract on dorsolateral prefrontal cortex

European Journal of Clinical Nutrition

Volumn 66, Issue 11, 2012, Pages 1187-1192

  Borgwardt, S ^a,b   Hammann, F ^a   Scheffler, K ^c   Kreuter, M ^d   Drewe, J ^a   Beglinger, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

^d Alpinia Laudanum Institute of Phytopharmaceutical Sciences   (Switzerland)

Author keywords

DLPFC; functional MRI; green tea; prefrontal cortex

Indexed keywords

GREEN TEA EXTRACT;

ADULT; ARTICLE; BRAIN ACTIVATION; BRAIN BLOOD FLOW; BRAIN FUNCTION; CARBONATED BEVERAGE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL TASK; MILK; NORMAL HUMAN; PREFRONTAL CORTEX; WORKING MEMORY;

ADULT; BRAIN MAPPING; CAMELLIA SINENSIS; DOUBLE-BLIND METHOD; HUMANS; MALE; MEMORY, SHORT-TERM; PLANT EXTRACTS; PREFRONTAL CORTEX; YOUNG ADULT;

EID: 84868655039     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.105     Document Type: Article

References (31)

1. Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea - a review. J Am Coll Nutr 2006; 25: 79-99.
2. Mandel S, Maor G, Youdim MB. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. J Mol Neurosci 2004; 24: 401-416.
3. Mandel S, Weinreb O, Amit T, Youdim MB. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3- gallate: implications for neurodegenerative diseases. J Neurochem 2004; 88: 1555-1569.
4. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S et al. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 2006; 83: 355-361.
5. Ng TP, Feng L, Niti M, Kua EH, Yap KB. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 2008; 88: 224-231.
6. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C et al. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 2009; 66: 442-451.
7. Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal ML et al. Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 2008; 64: 966-973.
8. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 2009; 66: 95-105.
9. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P et al. Induction of psychosis by D9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 2012; 69: 27-36.
10. Winton-Brown T, Allen P, Bhattacharrya S, Borgwardt SJ, Fusar-Poli P, Crippa JA et al. Modulation of auditory and visual processing by D-9-Tetrahydrocannabinol and Cannabidiol: an fMRI study. Neuropsychopharmacology 2011; 36: 1340-1348.
11. Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Fusar-Poli P et al. Acute effects of a single, oral dose of THC and cannabidiol administration in healthy volunteers. Curr Pharm Des 2012; e-pub ahead of print 7 June 2012.
12. Ettinger U, Williams SC, Fannon D, Premkumar P, Kuipers E, Moller HJ et al. Functional magnetic resonance imaging of a parametric working memory task in schizophrenia: relationship with performance and effects of antipsychotic treatment. Psychopharmacology 2011; 216: 17-27.
13. Owen WJ, Borowsky R, Sarty GEFMRI. of two measures of phonological processing in visual word recognition: ecological validity matters. Brain Lang 2004; 90: 40-46.
14. Smieskova R, Allen P, Simon A, Aston J, Bendfeldt K, Drewe J et al. Different duration of at-risk mental state associated with neurofunctional abnormalities Y a multimodal imaging study. Hum Brain Mapp 2011; e-pub ahead of print 16 September 2011; doi:10.1002/hbm.21360.
15. Hayasaka S, Nichols TE. Combining voxel intensity and cluster extent with permutation test framework. Neuroimage 2004; 23: 54-63.
16. Petersson KM, Nichols TE, Poline JB, Holmes AP. Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1239-1260.
17. Mai J, Paxinos G, Voss T. Atlas of the Human Brain. Academic Press: San Diego, 2008.
18. Dupont WD, Plummer Jr. WD . Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11: 116-128.
19. Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006; 136: 1043-1047.
20. Kaur T, Pathak CM, Pandhi P, Khanduja KL. Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn 2008; 67: 25-30.
21. Goswami M, Mund S, Ray A. Effects of some psychotropic agents on cognitive functions in rats. Indian J Physiol Pharmacol 1996; 40: 75-78.
22. Unno K, Takabayashi F, Kishido T, Oku N. Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol 2004; 39: 1027-1034.
23. Unno K, Takabayashi F, Yoshida H, Choba D, Fukutomi R, Kikunaga N et al. Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology 2007; 8: 89-95.
24. Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J Nutr Biochem 2008; 19: 619-626.
25. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 2008; 1214: 177-187.
26. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005; 25: 8807-8814.
27. Kim DK, Lee K. Inhibitory effect of trans-N-p-coumaroyl tryamine from the twigs of Celtis chinensis on the acetylcholinesterase. Arch Pharm Res 2003; 26: 735-738.
28. Melzig MF, Janka M. Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract. Phytomedicine 2003; 10: 494-498.
29. Ayoub S, Melzig MF. Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea. J Pharm Pharmacol 2006; 58: 495-501.
30. Chou CW, Huang WJ, Tien LT, Wang SJ. (-)-Epigallocatechin gallate, the most active polyphenolic catechin in green tea, presynaptically facilitates Ca2-dependent glutamate release via activation of protein kinase C in rat cerebral cortex. Synapse 2007; 61: 889-902.
31. Wilkinson D, Halligan P. The relevance of behavioural measures for functionalimaging studies of cognition. Nat Rev Neurosci 2004; 5: 67-73.